IPP Bureau

Japan Health Authority approves Biocon Biologics’ Ustekinumab BS, Biosimilar to J&J's Stelara
Japan Health Authority approves Biocon Biologics’ Ustekinumab BS, Biosimilar to J&J's Stelara

By IPP Bureau - January 07, 2025

The biosimilar Ustekinumab has been developed and manufactured by the company

Dr. Jitendra Singh announces CSIR's indigenously developed Paracetamol
Dr. Jitendra Singh announces CSIR's indigenously developed Paracetamol

By IPP Bureau - January 06, 2025

40th DSIR Foundation Day celebration marks 16 more technology transfers from CSIR to MSMEs

ICMR detects two cases of HMPV in Karnataka through routine surveillance
ICMR detects two cases of HMPV in Karnataka through routine surveillance

By IPP Bureau - January 06, 2025

ICMR will continue to track trends in HMPV circulation throughout the year

PM Modi lays foundation stone for new building for Central Ayurveda Research Institute in New Delhi
PM Modi lays foundation stone for new building for Central Ayurveda Research Institute in New Delhi

By IPP Bureau - January 06, 2025

2.92 acre facility will combine tradition and innovation, offering new opportunities for holistic healing, specialized clinics, and skill development to be constructed at a cost of around Rs. 185 crore

Zydus Lifesciences appoints Vikram Shukla as President - Parenteral Operations
Zydus Lifesciences appoints Vikram Shukla as President - Parenteral Operations

By IPP Bureau - January 06, 2025

He has 29+ years’ comprehensive experience in world-class Formulations and API (for US and EU requirements) mainly related to injectables

Cupid secures Rs. 14.91 crore order from Govt. of Tanzania for supply of male condoms
Cupid secures Rs. 14.91 crore order from Govt. of Tanzania for supply of male condoms

By IPP Bureau - January 05, 2025

The order, part of an international framework agreement is to be executed between February to April, 2025

CDSCO approves Wockhardt’s Mignaf for treatment of community acquired bacterial pneumonia
CDSCO approves Wockhardt’s Mignaf for treatment of community acquired bacterial pneumonia

By IPP Bureau - January 05, 2025

Wockhardt plans to launch Miqnaf in the Indian market in coming few months

Yatharth Hospital acquires hospital in New Delhi
Yatharth Hospital acquires hospital in New Delhi

By IPP Bureau - January 05, 2025

The acquired hospital is a well-established hospital based out of Model Town, New Delhi

Fire at the manufacturing plant of RPG Life Sciences at Navi Mumbai
Fire at the manufacturing plant of RPG Life Sciences at Navi Mumbai

By IPP Bureau - January 05, 2025

There was no casualty or loss of human life in the incidence

Godrej Agrovet launches Pride Hog feed range to boost pig health and immunity
Godrej Agrovet launches Pride Hog feed range to boost pig health and immunity

By IPP Bureau - January 04, 2025

Brings together industry experts to discuss preventive steps to protect pigs from African swine fever and best practises for pig farm management

Nano-formulation of darkness hormone could be therapeutic solution for Parkinson's disease
Nano-formulation of darkness hormone could be therapeutic solution for Parkinson's disease

By IPP Bureau - January 04, 2025

Parkinson's disease (PD) is one of the most common neurological disorders caused by the death of dopamine-secreting neurons in the brain

President Murmu addresses Golden Jubilee Celebrations of NIMHANS
President Murmu addresses Golden Jubilee Celebrations of NIMHANS

By IPP Bureau - January 04, 2025

Inaugurates new facilities to further NIMHANS’ mission of delivering cutting-edge care in mental health and neurosciences

President of India inaugurates KLE Cancer Hospital
President of India inaugurates KLE Cancer Hospital

By IPP Bureau - January 04, 2025

The President said that there is a need to spread more and more awareness regarding the causes, diagnosis and treatment of cancer

Veeda Group rebrands as Veeda Lifesciences
Veeda Group rebrands as Veeda Lifesciences

By IPP Bureau - January 03, 2025

The new brand name reflects the evolution from a generics-focused Contract Research Organization (CRO) to a drug development services enterprise

Abbott India appoints Prithwish K Banerji as Commercial Director - Women’s Health, Metabolics and International Business
Abbott India appoints Prithwish K Banerji as Commercial Director - Women’s Health, Metabolics and International Business

By IPP Bureau - January 03, 2025

Prithwish has close to 28 years of experience in a Commercial role

Latest Stories

Interviews

Packaging